Volume 12, Issue 5, September 2018

Index

REVIEW ONCOLOGY

Emerging concepts in urothelial cancer

D. De Maeseneer, K. Decaestecker, S. Rottey


Immuno-oncology in transitional cell Carcinoma

D. Schrijvers, T. Debacker


Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)

D. Arias, M.A. Flores, Á. Rodríguez, J. de Oliveira, L. Corrales, J.L. Firvida, E.S. Santos, L.E. Raez, C. Rolfo


PRACTICE GUIDELINES

PD-L1 Testing for Non-Small Cell Lung Cancer: Belgian Guidelines

P. Pauwels, M. Remmelink, D. Hoton, J. van Dorpe, K. Dhaene, F. Dome, A. Jouret-Mourin, B. Weynand, N. D’Haene


PHARMACOTHERAPY

Treatment options in patients with early breast cancer and BRCA-mutations or family history of cancer

M-D. Tkint de Roodenbeke, L. Buisserer, M. Piccart-Gebhart


RESEARCH

Blood sampling at home: a pilot project

D. Schrijvers, L. van Asch, A. Van Goethem, E. Heylen, P. de Schouwer, S. van Eeckhout, V. Verheyen


CONGRESS NEWS

Highlights of the 2018 Annual European Neuroendocrine Tumor Society (ENETS) Congress

W. Lybaert, T. Vandamme, G. Boons, T. Rondou, M. Twickler, I. Dero, F. van Fraeyenhove, L. De Backer, D. Van Genechten, M. Peeters


REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

P. Specenier


X